SciELO - Scientific Electronic Library Online

 
vol.19 número58Intervención educacional para la mejora en la asistencia al trabajo de parto normalMiedo ante la muerte y calidad de vida en adultos mayores índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Enfermería Global

versión On-line ISSN 1695-6141

Enferm. glob. vol.19 no.58 Murcia abr. 2020  Epub 18-Mayo-2020

http://dx.doi.org/eglobal.380951 

Originals

Risk factors for Healthcare-Associated Infections caused by KPC-producing Enterobacteriaceae: a case-control study

André Luiz Silva Alvim1  , Bráulio Roberto Gonçalves Marinho Couto2  , Andrea Gazzinelli1 

1Nursing school, Federal University of Minas Gerais, Minas Gerais, Brazil.

2Bioinformatics program, Unibh University Center, Belo Horizonte, Minas Gerais, Brazil.

ABSTRACT

Objective

To evaluate the risk factors for healthcare-associated infections caused by Klebsiella pneumoniaecarbapenemase producing Enterobacteriaceae.

Method

This is a retrospective case-control study that consisted of a sample of 82 infected patients and 164 controls, totaling 246 patients. Data collection was performed between January and May 2017 through search in the Automated Hospital Infection Control System and in the electronic patient records.

Results

Patients previously colonized with gram-negative microorganisms (OR: 10.7, 95% CI: 2-60, p=0.007), with cancer (OR: 20.8, 95% CI: 4-120, p<0.001), using a double lumen catheter (OR: 30.5, 95% CI: 2-382, p=0.008), with pressure injury (OR: 136.2, 95% CI: 11- 1623, p<0.001) and Intensive Care Unit stay (OR: 1.4, 95% CI: 1.2-1.6, p <0.001) had a greater chance of developing Healthcare-associated Infections caused by KPC-producing Enterobacteriaceaethan the control group. The area under the ROC curve showed a good overall performance (0.99, 95% CI: 0.992-0.998) of the final logistic regression model.

Conclusion

Previous colonization, cancer, double lumen catheter use, pressure injury and ICU stay were very important risk factors for the acquisition of infections in the hospital environment.

Key words: Enterobacteriaceae; Cross Infection; Drug Resistance, Microbial

INTRODUCTION

Healthcare-Associated Infections (HAIs) caused by Klebsiella pneumoniaeCarbapenemase (KPC)-producing Enterobacteriaceaerepresent a serious global public health problem. In the United States, at least 140,000 infections caused by Enterobacteriaceaeare reported annually, of which more than 9,000 are related to the production of carbapenemase, with more than 600 deaths per year. In Europe, between 2013 and 2015, all countries reported the occurrence of KPC, raising concerns due to the serious threat to patients, since there is little to no available treatment options. Since the first reports in Brazil in 2006, emerging cases have been warning the multidisciplinary team to put an effort in the reduce transmission or development of the antimicrobial resistance 1 2 3.

The wide spread dissemination of blaKPC genes and its resistance to most available antibiotics, in particular to carbapenems, has required preventive measures to reduce the risk of transmission of microorganisms in health services. We highlight that protocols to reduce transmission or how to reduce selective pressure need to be implemented if risk factors for the development of multiresistant organisms are identified 4 5.

Early detection of risk factors can reduce the cross transmission of microorganisms in the environment and decrease morbimortality caused by pathogens. However, there is still no consensus in the literature on which risk factors are directly associated with HAIs caused by KPC-producing Enterobacteriaceae.4 5 6The objective of this study was to evaluate the risk factors for healthcare-associated infections caused by KPC-producing Enterobacteriaceae.

METHOD

This is a retrospective case-control study that was developed in a general private hospital in Belo Horizonte, capital of Minas Gerais State, in the southeast region of Brazil. This hospital has an average of 1,130 patients hospitalized per month.

For the sample selection, a ratio of two controls was used for each case (2:1). There were 82 patients and 164 controls, totaling 246 patients. Cases were HAIs caused by KPC-producing Enterobacteriaceaebetween 2013 and 2016 and controls were no HAIs, but colonized with non-carbapenemase producing Enterobacteriaceae.

Patients presenting non-carbapenemase-producing K. pneumoniaewere randomly selected for the control group, selected by sex and proportional age. All patients, cases and controls, needed to be 18 years of age or older and have three days or more of hospitalization in the hospital setting in order to be included in the study.

Data collection was performed between January and May 2017 through search in the Automated Hospital Infection Control System and in the electronic patient records. A structured instrument was used to collect data related to the risk factors for infection.

The epidemiological data in the study hospital have been raised through active prospective search by nurses of the Infection Control Service. In this case, the National Healthcare Safety Network (NHSN) methodology of the Centers for Disease Control and Prevention (CDC) was used with the support of the Infection Control software. The date of event of the NHSN site-specific infection criterion was considered after the 3rd calendar day of admission to an inpatient location where day of admission is calendar day 1.

Potential risk factors were evaluated through the patient's electronic medical record. Data obtained included medications (eg, use of immunosuppressants, use of corticoid and use previous of antibiotics), comorbidities (eg, diabetes, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, cancer, hematological diseases), presence of device, hospitalization data (eg, transfer from another institution, previous hospitalization, previous colonization, current hospital stay, ICU stay, recent surgical procedure, surgical wound and pressure injury).

During the study period, the detection of a KPC-producing Enterobacteriaceaeoccurred by the Minimum Inhibitory Concentration (MIC) and the Modified Hodge Test (MHT). The bacterial suspension technique was used in sterile saline from isolated colonies on Mueller Hinton agar plate and disc diffusion test of the antibiotic imipenem in the center of the plate for incubation at 37°C for 18 to 24 hours.

After this initial detection, the isolated microorganisms were sent to the Central Public Health Laboratory for the implementation of the Polymerase Chain Reaction (PCR) “in house” methodology for molecular identification of the blaKPC gene. All methodologies followed the parameters determined by the Clinical & Laboratory Standards Institute and Technical Note 01/2013 of the Brazilian National Health Surveillance Agency 7 8.

For data analysis, an exploratory and descriptive statistical analysis was made. Univariate data analysis was performed using 95% confidence intervals (95% CI) for Odds Ratio (OR). The statistical hypothesis testing was evaluated using the Chi-square test and, when necessary, the Fisher's exact test, which considered a significance level of 5% (α=0.05) for bilateral tests. Non-parametric continuous variables were evaluated by the Mann-Whitney test.

Second, multiple logistic regression was used for multivariate analysis. All variables that obtained a p-value <0.20 were included. By the backward criterion and the Wald test, the least significant variables were removed one by one for the adjustment of the final model, which represented only the variables that obtained a p-value <0.05. All analyzes were carried out in the Epi Info®version 7 program.

The Receiver Operating Characteristic (ROC) curve was used to evaluate the predictive capacity of the final multivariate analysis model. In addition to the ROC curve, calculations were performed to simulate the chance of infection based on the risk factors found in the final multivariate analysis model, both calculated by the Microsoft Excel®2013 program. To simulate the chance of infection, the following formula was used:

Where: P = chance of infection; X1= Prior colonization by microorganisms (0 or 1); X2= Cancer (0 or 1); X3= Double lumen catheter (0 or 1); X4= Pressure injury (0 or 1); X5= Days of ICU stay (days).

The study was approved by the Research Ethics Committee of the Federal University of Minas Gerais, protocol number 1.821.249 (2016). This was a retrospective database study, therefore, it was not necessary to provide written informed consent by the patient. This study was carried out in accordance with the principles of the Declaration of Helsinki.

RESULTS

The study sample consisted of 82 cases and 164 controls, in a total of 246 patients. The average age of the two groups was 71 years (SD±13.6), with a minimum age of 30 and a maximum of 93. Most patients, both in the case and in the control groups, were males, married, white and with completed high school.

Most of HAIs caused by KPC-producing Enterobacteriaceaeoccurred by Klebsiella pneumoniae(68%) and were diagnosed in the blood (30%). There was a high prevalence of primary bloodstream infection (BSI) associated with central venous catheter (30%). The mortality rate was 62%.

Table 1showed the main findings of univariate and multivariate analysis related to HAIs caused by KPC-producing Enterobacteriaceae. Risk factors identified by the multivariate analysis were previous colonization by gram-negative microorganisms (OR: 10.7, 95% CI 2-60), cancer (OR: 20.8, 95% CI 4-120), double lumen catheter (OR: 30.5, 95% CI 2-382), pressure injury (OR: 136.2, 95% CI 11-162) and ICU stay (OR: 1.4, 95% CI 1.2-1.6) that increased the chance of developing HAIs caused by specific microorganisms.

Table 1: Univariate and multivariate analysis of risk factors related to HAIs caused by KPC-producing Enterobacteriaceae, Brazil, 2017. 

Source: Elaborated by the authors.

*Fisher's exact test

**Mann-Whitney test.

Abbreviations: AD, average days; ICU, Intensive Care Unit.

The area under the ROC curve evaluated the predictive capacity of the final multivariate analysis model using multiple logistic regression and showed a good overall performance (0.99, 95% CI: 0.992-0.998) in relation to sensitivity of the individual as an infectious event. The simulation of chance of infection based on the risk factors identified in the final model of multivariate analysis showed that the case-group had a predicted chance of infection concentrated between 90 and 100% because patients in this group had a greater number of risk factors (Figure 1).

Source: Elaborated by the authors

Figure 1: Curve of simulation of chance of infection, per patient, between the case and control group, Belo Horizonte, Minas Gerais, Brazil, 2017. 

DISCUSSION

The spread of blaKPC gene is a serious public health problem that directly affects clinical treatments in several health services. Since the first reports in Brazil, emerging cases have been warning about the importance of controlling these microorganisms which involves a great effort of the multidisciplinary team to reduce infections 9.

The mortality of 62% found in our study was similar to other studies that presented rates above 40%. Researchers explain that the aspects related to the complexity of the microorganism, the severity of patients, as well as their comorbidities directly influence the high mortality 4 10 11 12. Although the mix case analysis is not possible, the results suggest a high mortality among patients with KPC-producing Enterobacteriaceae.

Early identification of risk factors is important to plan for infection prevention and control strategies. Our study showed five risk factors associated with HAIs caused by KPC-producing Enterobacteriaceae: 1) previous colonization, 2) ICU stay, 3) double lumen catheter, 4) pressure injury and 5) cancer (active disease). Most of these risk factors can be identified early by health professionals.

We detected that the majority of the patients who had previous colonization used antimicrobials. This can be attributed to the use of broad-spectrum antibiotics that promote selection effects under the intestinal flora, provoking resistance under the local microbiota. Studies have been emphasizing the importance of implementing the components of infection prevention and control programmes to reduce the risk of cross-transmission 11 13 14 15.

Severe patients, often undergoing routine invasive procedures and exposed to the use of broad spectrum antibiotics in ICU, were considered at risk for developing HAIs. Intensive Care Unit designed to assist patients selected by type of disease or intervention, such as heart disease, neurological, surgical, among others. Therefore, ICU stay may contribute to mortality in those patients who are already infected with KPC-producing Enterobacteriaceaebecause they are more prone to the various infectious diseases 4 6 14 16.

The double lumen catheter is a type of invasive procedure commonly implanted in the ICU that had a strong association with KPC infection in our study. This device is an invasive vascular access that favors the entry of microorganisms and increases the chances of HAI 6 15 16 17. Studies showed renal diseases and dialysis as a factor predisposing to infections and that may be linked to the use of the double lumen catheter 10 18.

Pressure injury was presented as a risk factor that predisposes HAIs and was found mainly in the sacral region. In addition 10.4% of KPC-producing Enterobacteriaceaewere found in tissues of inpatients for tertiary care 17 19. Bed restriction, prolonged hospitalization, and ineffective decubitus change are factors prevenTable by the care team to reduce this adverse event 20.

Our study also showed that cancer as an active disease was one of the five risk factors among the case group and corroborated with a research that showed the different types of cancers associated with bacteremia caused by Klebsiella pneumoniae21. The aggressive procedures frequently used to treat the disease as well as repeated hospitalizations for chemotherapy contribute to the acquisition of microorganisms that predispose infections in the hospital environment 11 22.

We evaluated the risk factors found in the study individually, per patient, based on the final model of the multivariate analysis. The simulation of chance of infection showed the greater the number of risk factors attributed to the patient, increases the chance of getting infections.

Calculation of the chance of infection simulation showed that the case group had a predicted chance concentrated between 90 and 100% because they had a greater number of higher risk factors than the control group that remained below 10%. Most of the risk factors have modifiable characteristics and, therefore, can be quickly recognized by the multidisciplinary team and worked early in the hospital environment.

This retrospective case-control study has some limitations that must be recognized. The data collection occurred retrospectively and for this reason, problems were noted in the data records in the electronic medical record. The use of electronic medical records presented problems of missing data and incomplete records. There were shortcomings of medical prescriptions regarding the prescribed antibiotics, generating doubts regarding the monotherapy or combined therapy and thus, the researchers chose to disregard these variables.

CONCLUSION

In this study, it was possible to evaluate the risk factors for healthcare-associated infections caused by Klebsiella pneumoniaecarbapenemase producing Enterobacteriaceae. Previous colonization, cancer, double lumen catheter use, pressure injury and ICU stay were very important risk factors for the acquisition of infections in the hospital environment.

Most risk factors can be minimized when infection prevention and control programs are effectively implemented in the hospital setting. Health services should institute measures that reduce the spread of the KPC-producing Enterobacteriaceaeto implement programs that promote the rational use of antimicrobials, as an antimicrobial stewardship and to make a constant surveillance in all the aspects that correspond to the current guidelines of prevention and control of infections.

REFERENCIAS

1. Monteiro J, Santos AF. First Report of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil. Antimicrob Agents Chemother [Internet]. 2009 [cited 2018 Fev 14];53(1):333-34. DOI: http://dx.doi.org/10.1128/AAC.00736-08 [ Links ]

2. World Health Organization. Antimicrobial resistance Global Report on Surveillance. Geneva: World Health Organization [Internet]. 2014 [cited 2018 Fev 14]. Available from: https://www.who.int/drugresistance/documents/surveillancereport/en/Links ]

3. Centers for Disease Control and Prevention. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE). CRE Toolkit. Atlanta [Internet]. CDC; 2015 [cited 2018 Fev 14]. Available from: https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdfLinks ]

4. Mariappan S, Sekar U, Kamalanathan A. Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes. Int J Appl Basic Med Res [Internet]. 2017 [cited 2018 Fev 14];7(1):32-39. DOI: http://dx.doi.org/10.4103/2229-516X.198520 [ Links ]

5. Abboud CS, de Souza EE, Zandonadi EC, Borges LS, Miglioli L, Monaco FC, et al. Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control. J Hosp Infect [Internet]. 2016 [cited 2018 Fev 14];94(1):60-4. DOI: http://dx.doi.org/10.1016/j.jhin.2016.06.010 [ Links ]

6. Wang Q, Zhang Y, Yao X, Xian H, Liu Y, Li H, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis [Internet]. 2016 [cited 2018 Fev 15];35(10):1679-89. DOI: http://dx.doi.org/10.1007/s10096-016-2710-0 [ Links ]

7. Agência Nacional de Vigilância Sanitária. Nota Técnica nº 01/2013 - Medidas de prevenção e controle de infecções por Enterobactérias multiresistentes. Brasília: ANVISA [Internet]. 2013 [cited 2018 Fev 14]. Available from: http://portal.anvisa.gov.br/documents/33852/271858/Nota+t%C3%A9cnica+n%C2%BA+01+de+2013/5be89853-7eca-4b4b-98e4-5096b9f5a2ecLinks ]

8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eleventh Edition. CLSI document M02-A11. Wayne, PA: Clinical and Laboratory Standards Institute [Internet]. 2012 [cited 2018 Fev 14]. Available from: https://clsi.org/about/about-clsi/about-clsi-antimicrobial-and-antifungal-susceptibility-testing-resources/Links ]

9. Borges FK, Moraes TA, Drebes CVE, Silva ALT, Cassol R, Falci DR. Perfil dos pacientes colonizados por enterobactérias produtoras de KPC em hospital terciário de Porto Alegre, Brasil. Clin Biomed Res [Internet]. 2015 [cited 2018 Fev 15];35(1). DOI: http://dx.doi.org/10.4322/2357-9730.51134 [ Links ]

10. Carrilho C, Oliveira LM, Gaudereto J, Perozin JS, Urbano MR, Camargo CH, et al. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome. BMC Infect Dis [Internet]. 2016 [cited 2018 Fev 15];16:629. DOI: http://dx.doi.org/10.1186/s12879-016-1979-z [ Links ]

11. Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. Clin Microbiol Infect [Internet]. 2015 [cited 2018 Fev 16];21(12):1106.e1-8. DOI: http://dx.doi.org/10.1016/j.cmi.2015.08.001 [ Links ]

12. Souza ES, Belei RA, Carrilho CMDM, Matsuo T, Yamada-Ogatta SF, Andrade G, et al. Mortalidade e riscos associados a infecção relacionada à assistência à saúde. Texto Contexto Enferm [Internet]. 2015 [cited 2018 Fev 16]; 24(1):220-8. DOI: http://dx.doi.org/10.1590/0104-07072015002940013 [ Links ]

13. Lubert C, Becker-Rux D, Rodloff AC, Laudi S, Busch T, Bartels M, et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection [Internet]. 2014 [cited 2018 Fev 15];42(2):309-16. DOI: http://dx.doi.org/10.1007/s15010-013-0547-3 [ Links ]

14. Papadimitrious-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother [Internet]. 2012 [cited 2018 Fev 16];67(12):2976-81. DOI: http://dx.doi.org/10.1093/jac/dks316 [ Links ]

15. Cronin KM, Poy Lorenzo YS, Olenski ME, Bloch AE, Visvanathan K, Waters MJ, et al. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case-control study. J Hosp Infect [Internet]. 2017 [cited 2018 Fev 16];96(2):111-15. DOI: http://dx.doi.org/10.1016/j.jhin.2017.02.010 [ Links ]

16. Papadimitrious-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis [Internet]. 2013 [cited 2018 Fev 15];77(2):169-73. DOI: http://dx.doi.org/10.1016/j.diagmicrobio.2013.06.007 [ Links ]

17. Ling ML, Tee YM, Tan SG, Amim IM, How KB, Tan KY, et al. Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control [Internet]. 2015 [cited 2018 Fev 16];4:26. DOI: http://dx.doi.org/10.1186/s13756-015-0066-3 [ Links ]

18. Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother [Internet]. 2015 [cited 2018 Fev 18];70(7):2133-43. DOI: http://dx.doi.org/10.1093/jac/dkv086 [ Links ]

19. Murri R, Fiori B, Spanu T, Mastrorosa I, Giovannenze F, Taccari F, et al. Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection [Internet]. 2017 [cited 2018 Fev 18];45(2):209-213. DOI: http://dx.doi.org/10.1007/s15010-016-0968-x [ Links ]

20. Borghardt AT, Prado TN, Bicudo SDS, Castrol DS, BringuenteI ME. Pressure ulcers in critically ill patients: incidence and associated factors. Rev Bras Enferm [Internet]. 2016 [cited 2018 Fev 15];69(3):460-67. DOI: http://dx.doi.org/10.1590/0034-7167.2016690307i [ Links ]

21. Meatherall B, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med [Internet]. 2009 [cited 2018 Fev 16];122(9):866-73. DOI: http://dx.doi.org/10.1016/j.amjmed.2009.03.034 [ Links ]

22. Guerra MR, Bustamante-Teixeira MT, Corrêa CSL, Bustamante-Teixeira MT, Corrêa CSL , Abreu DMX, Curado MP, Mooney M, et al. Magnitude e variação da carga da mortalidade por câncer no Brasil e Unidades da Federação, 1990 e 2015. Rev Bras Epidemiol [Internet]. 2017 [cited 2018 Fev 16];20(Suppl 1):102-15. DOI: http://dx.doi.org/10.1590/1980-5497201700050009 [ Links ]

Received: May 27, 2019; Accepted: November 09, 2019

André Luiz Silva Alvim: andrealvim1@hotmail.com

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons